Literature DB >> 10733587

Mammalian SWI-SNF complexes contribute to activation of the hsp70 gene.

I L de La Serna1, K A Carlson, D A Hill, C J Guidi, R O Stephenson, S Sif, R E Kingston, A N Imbalzano.   

Abstract

ATP-dependent chromatin-remodeling complexes are conserved among all eukaryotes and function by altering nucleosome structure to allow cellular regulatory factors access to the DNA. Mammalian SWI-SNF complexes contain either of two highly conserved ATPase subunits: BRG1 or BRM. To identify cellular genes that require mammalian SWI-SNF complexes for the activation of gene expression, we have generated cell lines that inducibly express mutant forms of the BRG1 or BRM ATPases that are unable to bind and hydrolyze ATP. The mutant subunits physically associate with at least two endogenous members of mammalian SWI-SNF complexes, suggesting that nonfunctional, dominant negative complexes may be formed. We determined that expression of the mutant BRG1 or BRM proteins impaired the ability of cells to activate the endogenous stress response gene hsp70 in response to arsenite, a metabolic inhibitor, or cadmium, a heavy metal. Activation of hsp70 by heat stress, however, was unaffected. Activation of the heme oxygenase 1 promoter by arsenite or cadmium and activation of the cadmium-inducible metallothionein promoter also were unaffected by the expression of mutant SWI-SNF components. Analysis of a subset of constitutively expressed genes revealed no or minimal effects on transcript levels. We propose that the requirement for mammalian SWI-SNF complexes in gene activation events will be specific to individual genes and signaling pathways.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10733587      PMCID: PMC85505          DOI: 10.1128/MCB.20.8.2839-2851.2000

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  92 in total

1.  Chromatin-remodelling factor CHRAC contains the ATPases ISWI and topoisomerase II.

Authors:  P D Varga-Weisz; M Wilm; E Bonte; K Dumas; M Mann; P B Becker
Journal:  Nature       Date:  1997-08-07       Impact factor: 49.962

2.  RB and hbrm cooperate to repress the activation functions of E2F1.

Authors:  D Trouche; C Le Chalony; C Muchardt; M Yaniv; T Kouzarides
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-14       Impact factor: 11.205

Review 3.  Histone acetylation and transcriptional regulatory mechanisms.

Authors:  K Struhl
Journal:  Genes Dev       Date:  1998-03-01       Impact factor: 11.361

4.  ACF, an ISWI-containing and ATP-utilizing chromatin assembly and remodeling factor.

Authors:  T Ito; M Bulger; M J Pazin; R Kobayashi; J T Kadonaga
Journal:  Cell       Date:  1997-07-11       Impact factor: 41.582

5.  Purification and biochemical heterogeneity of the mammalian SWI-SNF complex.

Authors:  W Wang; J Côté; Y Xue; S Zhou; P A Khavari; S R Biggar; C Muchardt; G V Kalpana; S P Goff; M Yaniv; J L Workman; G R Crabtree
Journal:  EMBO J       Date:  1996-10-01       Impact factor: 11.598

6.  Disruption of downstream chromatin directed by a transcriptional activator.

Authors:  S A Brown; R E Kingston
Journal:  Genes Dev       Date:  1997-12-01       Impact factor: 11.361

7.  The hbrm and BRG-1 proteins, components of the human SNF/SWI complex, are phosphorylated and excluded from the condensed chromosomes during mitosis.

Authors:  C Muchardt; J C Reyes; B Bourachot; E Leguoy; M Yaniv
Journal:  EMBO J       Date:  1996-07-01       Impact factor: 11.598

8.  RSC, an essential, abundant chromatin-remodeling complex.

Authors:  B R Cairns; Y Lorch; Y Li; M Zhang; L Lacomis; H Erdjument-Bromage; P Tempst; J Du; B Laurent; R D Kornberg
Journal:  Cell       Date:  1996-12-27       Impact factor: 41.582

9.  Epstein-Barr virus nuclear protein 2 (EBNA2) binds to a component of the human SNF-SWI complex, hSNF5/Ini1.

Authors:  D Y Wu; G V Kalpana; S P Goff; W H Schubach
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

10.  Adenovirus E1A specifically blocks SWI/SNF-dependent transcriptional activation.

Authors:  M E Miller; B R Cairns; R S Levinson; K R Yamamoto; D A Engel; M M Smith
Journal:  Mol Cell Biol       Date:  1996-10       Impact factor: 4.272

View more
  71 in total

1.  BAF60A mediates interactions between the microphthalmia-associated transcription factor and the BRG1-containing SWI/SNF complex during melanocyte differentiation.

Authors:  Shweta Aras; Srinivas Vinod Saladi; Tupa Basuroy; Himangi G Marathe; Patrick Lorès; Ivana L de la Serna
Journal:  J Cell Physiol       Date:  2018-12-04       Impact factor: 6.384

2.  An improved restriction enzyme accessibility assay for analyzing changes in chromatin structure in samples of limited cell number.

Authors:  Yasuyuki Ohkawa; Chandrashekara Mallappa; Caroline S Dacwag Vallaster; Anthony N Imbalzano
Journal:  Methods Mol Biol       Date:  2012

3.  Heterozygous missense mutations in SMARCA2 cause Nicolaides-Baraitser syndrome.

Authors:  Jeroen K J Van Houdt; Beata Anna Nowakowska; Sérgio B Sousa; Barbera D C van Schaik; Eve Seuntjens; Nelson Avonce; Alejandro Sifrim; Omar A Abdul-Rahman; Marie-José H van den Boogaard; Armand Bottani; Marco Castori; Valérie Cormier-Daire; Matthew A Deardorff; Isabel Filges; Alan Fryer; Jean-Pierre Fryns; Simone Gana; Livia Garavelli; Gabriele Gillessen-Kaesbach; Bryan D Hall; Denise Horn; Danny Huylebroeck; Jakub Klapecki; Malgorzata Krajewska-Walasek; Alma Kuechler; Matthew A Lines; Saskia Maas; Kay D Macdermot; Shane McKee; Alex Magee; Stella A de Man; Yves Moreau; Fanny Morice-Picard; Ewa Obersztyn; Jacek Pilch; Elizabeth Rosser; Nora Shannon; Irene Stolte-Dijkstra; Patrick Van Dijck; Catheline Vilain; Annick Vogels; Emma Wakeling; Dagmar Wieczorek; Louise Wilson; Orsetta Zuffardi; Antoine H C van Kampen; Koenraad Devriendt; Raoul Hennekam; Joris Robert Vermeesch
Journal:  Nat Genet       Date:  2012-02-26       Impact factor: 38.330

4.  Protein arginine methyltransferase 7 regulates cellular response to DNA damage by methylating promoter histones H2A and H4 of the polymerase δ catalytic subunit gene, POLD1.

Authors:  Vrajesh Karkhanis; Li Wang; Sookil Tae; Yu-Jie Hu; Anthony N Imbalzano; Saïd Sif
Journal:  J Biol Chem       Date:  2012-07-02       Impact factor: 5.157

5.  BRG1 helps RNA polymerase II to overcome a nucleosomal barrier during elongation, in vivo.

Authors:  Alicia Subtil-Rodríguez; José C Reyes
Journal:  EMBO Rep       Date:  2010-09-10       Impact factor: 8.807

6.  Myogenic microRNA expression requires ATP-dependent chromatin remodeling enzyme function.

Authors:  Chandrashekara Mallappa; Brian T Nasipak; Letitiah Etheridge; Elliot J Androphy; Stephen N Jones; Charles G Sagerström; Yasuyuki Ohkawa; Anthony N Imbalzano
Journal:  Mol Cell Biol       Date:  2010-04-26       Impact factor: 4.272

7.  SWI/SNF chromatin remodeling enzyme ATPases promote cell proliferation in normal mammary epithelial cells.

Authors:  Nathalie Cohet; Kathleen M Stewart; Rajini Mudhasani; Ananthi J Asirvatham; Chandrashekara Mallappa; Karen M Imbalzano; Valerie M Weaver; Anthony N Imbalzano; Jeffrey A Nickerson
Journal:  J Cell Physiol       Date:  2010-06       Impact factor: 6.384

8.  Human SWI/SNF-associated PRMT5 methylates histone H3 arginine 8 and negatively regulates expression of ST7 and NM23 tumor suppressor genes.

Authors:  Sharmistha Pal; Sheethal N Vishwanath; Hediye Erdjument-Bromage; Paul Tempst; Saïd Sif
Journal:  Mol Cell Biol       Date:  2004-11       Impact factor: 4.272

9.  MITF interacts with the SWI/SNF subunit, BRG1, to promote GATA4 expression in cardiac hypertrophy.

Authors:  Gaurav Mehta; Sivarajan Kumarasamy; Jian Wu; Aaron Walsh; Lijun Liu; Kandace Williams; Bina Joe; Ivana L de la Serna
Journal:  J Mol Cell Cardiol       Date:  2015-09-24       Impact factor: 5.000

10.  Ligand-specific dynamics of the progesterone receptor in living cells and during chromatin remodeling in vitro.

Authors:  Geetha V Rayasam; Cem Elbi; Dawn A Walker; Ronald Wolford; Terace M Fletcher; Dean P Edwards; Gordon L Hager
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.